Travatan Drops

Travatan Drops

Description:

Travatan 0.004% Eye Drops 2.5 ml is a prescription ophthalmic medicine containing travoprost, a synthetic prostaglandin f2-alpha analogue used to lower elevated intraocular pressure (iop). It is primarily indicated for the treatment of open-angle glaucoma and ocular hypertension in adults. Travatan Drops work by increasing the outflow of aqueous humor, mainly through the uveoscleral pathway, helping to protect the optic nerve and reduce the risk of vision loss associated with high eye pressure. This sterile eye drop solution is for topical use in the eyes only and should be used under the supervision of an eye care specialist.

Indications:

• Treatment of elevated intraocular pressure (iop) in patients with open-angle glaucoma.
• Management of ocular hypertension in adults where high eye pressure may lead to glaucoma or optic nerve damage.
• Helps reduce the risk of progressive visual field loss associated with uncontrolled intraocular pressure.

Active Ingredients / Key Components:

• Travoprost 0.004% (0.04 mg/ml) – prostaglandin f2-alpha analogue ophthalmic antiglaucoma agent.
• Other ingredients (excipients): The full list of inactive ingredients (e.g., preservatives, buffering agents, stabilizers) is not available in the provided information. Please refer to the official package insert for a complete ingredient list.

Dosage & Administration / How to Use:

• Adults (including elderly): Apply one drop of Travatan 0.004% in the affected eye(s) once daily in the evening, or exactly as prescribed by your ophthalmologist.
• Do not use more than once daily, as more frequent dosing may reduce the intraocular pressure-lowering effect.
• Wash hands thoroughly before use.
• Tilt your head back, gently pull down the lower eyelid to create a small pocket, and instill one drop into the conjunctival sac. Avoid touching the dropper tip to the eye, eyelids, or any surface to prevent contamination.
• After instillation, close the eye gently and apply light pressure with a finger to the inner corner of the eye (near the nose) for 1–2 minutes to reduce systemic absorption.
• If using other topical ophthalmic medications, wait at least 5 minutes between products. Travatan is usually applied last if an ointment is used.
• If a dose is missed, apply it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• For ophthalmic use only. Do not swallow or inject.
• Use in children and adolescents: Safety and efficacy in pediatric patients have not been fully established; use only if specifically directed by a specialist.

Clinical Benefits:

• Effectively reduces elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension.
• Helps protect the optic nerve and preserve visual function by lowering eye pressure.
• Once-daily evening dosing supports convenient and consistent treatment adherence.
• Proven prostaglandin analogue mechanism enhances uveoscleral outflow of aqueous humor for sustained iop control.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to travoprost or any component of the formulation.
• Travatan may gradually change the color of the iris (increased brown pigmentation), particularly in eyes with mixed-color irides (e.g., blue-brown, green-brown, hazel-brown). This change may be permanent and more noticeable if only one eye is treated.
• May cause darkening of eyelid skin and increased length, thickness, number, and/or pigmentation of eyelashes. These changes may be reversible or partially reversible after discontinuation.
• Use with caution in patients with a history of intraocular inflammation (uveitis) or active ocular inflammation, as prostaglandin analogues may exacerbate inflammation.
• Use with caution in patients with aphakia, pseudophakia with torn posterior lens capsule, or known risk factors for macular edema, as macular edema has been reported with prostaglandin analogues.
• Remove contact lenses before instillation; lenses may be reinserted after at least 15 minutes, especially if the product contains preservatives that can be absorbed by soft lenses. Check the package insert for specific preservative information.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Travoprost may be absorbed systemically; use only if the potential benefit justifies the potential risk.
• Inform your doctor about all other eye medications and systemic treatments you are using to avoid interactions or overlapping effects.
• Do not use if the solution changes color, becomes cloudy, or if the seal is broken before first use.
• Consult your doctor before use if you have severe eye infection, eye injury, recent eye surgery, or other serious eye conditions.
• Consult your doctor before use if you have severe respiratory disease or cardiovascular conditions, although systemic effects are rare.
• Not intended to diagnose, treat, cure, or prevent any disease outside its approved ophthalmic indications.
• Keep out of reach of children.

Side Effects:

• Common side effects may include eye redness, eye irritation, burning or stinging sensation, itching, dry eye, foreign body sensation, or blurred vision immediately after instillation.
• Other possible effects: increased eyelash growth, eyelash darkening, eyelid skin darkening, and gradual change in iris color (increased brown pigmentation).
• Less common but more serious side effects may include eye pain, severe eye irritation, vision changes, eyelid swelling, signs of eye infection (discharge, marked redness, sensitivity to light), or symptoms of macular edema (worsening central vision). Seek immediate medical attention if these occur.
• Systemic side effects are rare but may include headache or mild systemic discomfort. Report any unusual symptoms to your doctor.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Follow any additional storage instructions on the package insert (e.g., temperature range). Discard the bottle within the period specified after first opening, as indicated by the manufacturer.

Specifications:

• Product type: Ophthalmic prescription medicine (antiglaucoma eye drops).
• Active ingredient concentration: Travoprost 0.004% (0.04 mg/ml).
• Form: Sterile eye drops solution.
• Pack size: 2.5 ml bottle.
• Route of administration: Ophthalmic (for use in the eyes only).

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.